Canada markets closed

Bioventus Inc. (BVS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.75+0.03 (+0.52%)
At close: 04:00PM EDT
5.92 +0.17 (+2.96%)
After hours: 06:01PM EDT
Show:
Annual

Balance Sheet

All numbers in thousands
Breakdown
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Assets
Current Assets
Cash
Cash And Cash Equivalents
36,964
30,186
43,933
86,839
-
Total Cash
36,964
30,186
43,933
86,839
-
Net Receivables
122,789
136,295
124,963
88,283
-
Inventory
91,333
84,766
61,688
29,120
-
Other Current Assets
16,913
18,551
15,003
7,552
-
Total Current Assets
267,999
272,575
263,103
211,794
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
90,462
74,940
63,271
42,161
-
Accumulated Depreciation
-40,504
-30,794
-23,100
-20,321
-
Net property, plant and equipment
49,958
44,146
40,171
21,840
-
Equity and other investments
-
2,636
29,291
19,382
3,308
Goodwill
7,462
7,462
147,623
49,800
-
Intangible Assets
482,350
639,851
695,193
191,650
-
Other long-term assets
3,141
408,615
79,291
19,382
-
Total non-current assets
542,911
1,100,074
962,759
282,672
-
Total Assets
810,910
1,372,649
1,225,862
494,466
-
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Current Debt
27,848
33,056
18,038
15,000
-
Accounts Payable
23,038
36,697
16,915
4,422
-
Accrued liabilities
85,635
80,623
91,287
58,844
-
Other Current Liabilities
24,518
139,641
24,940
24,960
-
Total Current Liabilities
175,497
304,017
180,859
122,589
-
Non-current liabilities
Long Term Debt
366,998
385,010
339,644
173,378
-
Deferred taxes liabilities
1,213
2,248
133,518
3,362
-
Other long-term liabilities
46,084
40,241
38,052
21,728
-
Total non-current liabilities
414,295
656,410
511,214
227,717
-
Total Liabilities
589,792
960,427
692,073
350,306
-
Stockholders' Equity
Common Stock
79
78
75
144,160
-
Retained Earnings
-321,536
-165,306
-6,602
0
-
Accumulated other comprehensive income
794
-110
179
0
-
Total stockholders' equity
173,591
325,238
458,924
144,160
-
Total liabilities and stockholders' equity
810,910
1,372,649
1,225,862
494,466
-